Trial · NCT02416271
The Forteo Alendronate Comparator Trial
NCT02416271, Phase 4, Completed, Eli Lilly and Company
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Forteo Alendronate Comparator Trial. Trials, record NCT02416271. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02416271
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Forteo Alendronate Comparator Trial
- NCT number
- NCT02416271
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 203 participants, actual
- Lead sponsor
- Eli Lilly and Company
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Alendronate, Calcium, Vitamin D, Placebo-Oral, Placebo-SC
- First posted
- 2015-04-14
- Last updated
- 2015-04-14
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change from Baseline to 18 Months in Lumbar Spine BMD | Baseline, 18 Months | |
| Secondary | Percent Change from Baseline in Lumbar Spine BMD | Baseline, 3 Months, 6 Months, 12 Months | |
| Secondary | Percent Change from Baseline in Total Hip and Femoral Neck BMD | Baseline, 12 Months, 18 Months | |
| Secondary | Percent Change from Baseline in Trabecular Volumetric BMD at the Lumbar Spine | Baseline, 6 Months, 18 Months | |
| Secondary | Percent Change from Baseline in Cortical BMD at the Femoral Neck | Baseline, 6 Months, 18 Months | |
| Secondary | Percent Change from Baseline in Trabecular BMD at the Femoral Neck | Baseline, 6 Months, 18 Months | |
| Secondary | Percent Change from Baseline in Biochemical Marker -Serum Procollagen I C-Terminal Propeptide (PICP) | Baseline, 1 Month, 3 Months, 6 Months, 12 Months | |
| Secondary | Percent Change from Baseline in Biochemical Marker -Serum Procollagen I N-Terminal Propeptide (PINP) | Baseline, 1 Month, 3 Months, 6 Months, 12 Months | |
| Secondary | Percent Change from Baseline in Biochemical Marker -Bone-Specific Alkaline Phosphatase (BSAP) | Baseline, 1 Month, 3 Months, 6 Months, 12 Months | |
| Secondary | Percent Change from Baseline in Biochemical Marker -Urinary N-Telopeptide (NTX) | Baseline, 1 Month, 3 Months, 6 Months, 12 Months |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02416271
GET https://conductscience.org/api/trials/v1/NCT02416271/registered